Sientra, Inc. (NASDAQ:SIEN)’s share price fell 0% during trading on Wednesday following a dissappointing earnings announcement. The stock traded as low as $13.00 and last traded at $13.45. 664,466 shares changed hands during trading, an increase of 439% from the average session volume of 123,345 shares. The stock had previously closed at $13.45.

The medical instruments supplier reported ($0.74) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.68) by ($0.06). Sientra had a negative net margin of 173.83% and a negative return on equity of 52.30%. The business had revenue of $9.80 million during the quarter, compared to analyst estimates of $10.54 million. During the same quarter last year, the business earned ($0.55) earnings per share. Sientra’s revenue for the quarter was up 50.8% on a year-over-year basis.

A number of research firms have recently issued reports on SIEN. Canaccord Genuity reiterated a “buy” rating and issued a $14.00 price objective on shares of Sientra in a report on Sunday, October 8th. Stifel Nicolaus reiterated a “hold” rating and issued a $14.00 price objective (up from $11.00) on shares of Sientra in a report on Wednesday, September 27th. William Blair upgraded shares of Sientra from a “market perform” rating to an “outperform” rating in a report on Wednesday, September 13th. Zacks Investment Research downgraded shares of Sientra from a “hold” rating to a “sell” rating in a report on Tuesday, August 15th. Finally, Lake Street Capital reiterated a “buy” rating and issued a $15.00 price objective (up from $11.00) on shares of Sientra in a report on Tuesday, August 8th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $13.75.

Institutional investors and hedge funds have recently modified their holdings of the stock. JPMorgan Chase & Co. acquired a new position in Sientra during the second quarter worth $101,000. Nationwide Fund Advisors increased its holdings in Sientra by 260.4% during the second quarter. Nationwide Fund Advisors now owns 10,963 shares of the medical instruments supplier’s stock worth $107,000 after buying an additional 7,921 shares during the last quarter. Accredited Investors Inc. acquired a new position in Sientra during the second quarter worth $115,000. Wells Fargo & Company MN increased its holdings in Sientra by 0.3% during the first quarter. Wells Fargo & Company MN now owns 12,871 shares of the medical instruments supplier’s stock worth $108,000 after buying an additional 40 shares during the last quarter. Finally, Highbridge Capital Management LLC acquired a new position in Sientra during the first quarter worth $117,000. Institutional investors and hedge funds own 77.59% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/11/09/sientra-inc-sien-stock-price-down-0-after-earnings-miss.html.

Sientra Company Profile

Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.

Receive News & Stock Ratings for Sientra Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra Inc. and related stocks with our FREE daily email newsletter.